Earnings History Data for Crinetics Pharmaceuticals (CRNX) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Crinetics Pharmaceuticals

Crinetics Pharmaceuticals Inc is a clinical stage pharmaceutical company. It focuses on the discovery, development and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. The company's product pipeline consists of CRN00808 for the treatment of Acromegaly, CRN02481 for the treatment of Hyperinsulinemias and CRN01941 for the treatment of Neuroendocrine Tumors which are in clinical stage. Crinetics Pharmaceuticals Inc is based in San Diego, United States.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
28-02-2024	AH		CRNX	Crinetics Pharmaceuticals	2,462	-0.90	-0.89	0.00	Crinetics Pharmaceuticals GAAP EPS of -$0.90 misses by $0.02 [2/28/2024 4:55 PM]	41.03	-1.73 (-4.05%)	45.16	2.40 (5.61%)	15.23 - 47.48	1,032,681	630,000	2,471
Crinetics Pharmaceuticals GAAP EPS of -$0.90 misses by $0.02 [2/28/2024 4:55 PM]
07-11-2023	AH		CRNX	Crinetics Pharmaceuticals	1,679	-1.01	-0.89	0.00	Crinetics Pharmaceuticals GAAP EPS of -$1.01 misses by $0.15, revenue of $0.35M beats by $0.21M [11/7/2023 5:35 PM]	28.44	-1.08 (-3.66%)	30.00	0.48 (1.63%)	15.23 - 31.41	1,283,898	870,000	125,752
Crinetics Pharmaceuticals GAAP EPS of -$1.01 misses by $0.15, revenue of $0.35M beats by $0.21M [11/7/2023 5:35 PM]
08-08-2023	PM		CRNX	Crinetics Pharmaceuticals	1,010	-0.94	-0.85	0.00	Crinetics Pharmaceuticals GAAP EPS of -$0.94, revenue of $1M [8/8/2023 8:00 AM]	17.30	-0.70 (-3.89%)	0.0	0.0 (0.00%)	15.23 - 24.58	475,568	450,000	0
Crinetics Pharmaceuticals GAAP EPS of -$0.94, revenue of $1M [8/8/2023 8:00 AM]
04-05-2023	AH	After the close (May 4)	CRNX	Crinetics Pharmaceuticals	1,126	-0.85	-0.82	0.00	Crinetics Pharmaceuticals GAAP EPS of -$0.85 misses by $0.01, revenue of $2.67M beats by $2.43M [5/4/2023 5:31 PM]	22.33	0.96 (4.49%)	21.37	0.0 (0.00%)	15.23 - 24.25	1,394,183	470,000	17,496
Crinetics Pharmaceuticals GAAP EPS of -$0.85 misses by $0.01, revenue of $2.67M beats by $2.43M [5/4/2023 5:31 PM]
28-02-2023	AH		CRNX	Crinetics Pharmaceuticals	1,052	-0.84	-0.82	0.00	Crinetics Pharmaceuticals GAAP EPS of -$0.84 misses by $0.01, revenue of $0.71M beats by $0.41M [2/28/2023 5:46 PM]	19.59	-0.05 (-0.25%)	19.64	0.0 (0.00%)	15.37 - 27.86	565,152	360,000	319,814
Crinetics Pharmaceuticals GAAP EPS of -$0.84 misses by $0.01, revenue of $0.71M beats by $0.41M [2/28/2023 5:46 PM]
12-08-2022	PM		CRNX	Crinetics Pharmaceuticals	1,165	-0.81	-0.62	0.00	Crinetics Pharmaceuticals GAAP EPS of -$0.81 misses by $0.15, revenue of $0.44M misses by $0.28M [8/12/2022 8:28 AM]	20.57	-0.02 (-0.10%)	20.29	-0.30 (-1.46%)	15.91 - 28.95	587,556	270,000	100
Crinetics Pharmaceuticals GAAP EPS of -$0.81 misses by $0.15, revenue of $0.44M misses by $0.28M [8/12/2022 8:28 AM]
10-08-2021	AH		CRNX	Crinetics Pharmaceuticals, Inc.	662.00	-0.70	-0.60	0.00	Crinetics Pharmaceuticals EPS misses by $0.10 [8/10/2021 4:48 PM]	19.18	1.58 (8.98%)	19.00	1.40 (7.95%)	11.61 - 21.64	566,112	130,000	734
Crinetics Pharmaceuticals EPS misses by $0.10 [8/10/2021 4:48 PM] Crinetics Pharmaceuticals posts positive data from early-stage CRN04894 trial [8/10/2021 4:13 PM] Crinetics Pharmaceuticals Reports Second Quarter 2021 Financial Results and Provides Corporate Update [Aug-10-21 04:02PM] Crinetics Pharmaceuticals Oral ACTH Antagonist, CRN04894, Demonstrates Pharmacologic Proof-of-Concept with Dose-Dependent Cortisol Suppression in Single Ascending Dose Portion of Phase 1 Study [Aug-10-21 04:01PM]
06-05-2021	AH		CRNX	Crinetics Pharmaceuticals, Inc.	662.00	-0.69	-0.65	0.00	Crinetics Pharmaceuticals EPS misses by $0.04 [5/6/2021 5:12 PM]	16.94	0.29 (1.74%)	0.0	0.0 (0.00%)	11.61 - 23.70	53,373	90,000	0
Crinetics Pharmaceuticals EPS misses by $0.04 [5/6/2021 5:12 PM] Crinetics Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides Corporate Update [May-06-21 04:05PM]
30-03-2021	AH	4:10 PM ET (Mar 30)	CRNX	Crinetics Pharmaceuticals, Inc.	521.16	-0.66	-0.58	-0.60	Crinetics Pharmaceuticals EPS misses by $0.08 [3/30/2021 4:23 PM]	15.29	-0.15 (-0.97%)	15.44	0.0 (0.00%)	11.61 - 23.70	86,820	120,000	3,295
Crinetics Pharmaceuticals EPS misses by $0.08 [3/30/2021 4:23 PM] Crinetics Pharmaceuticals, Inc. to Host Earnings Call [Mar-30-21 02:30PM] Crinetics Pharmaceuticals Announces 2021 Clinical Plans and Reports Fourth Quarter and Full Year 2020 Financial Results [Mar-30-21 04:05PM]